article thumbnail

This app-guided psychedelic treatment works when antidepressants don’t

The Cannigma

Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment? Ketamine treatment for depression may be one of the biggest leaps forward in mental healthcare in decades.

Treatment 138
article thumbnail

Mississippi Becomes 37th State to Legalize Medical Cannabis With a Law that Provides Limited Access to Patients

Americans for Safe Access

On February 2, 2022, Governor Tate Reeves chose to sign SB 2095 into law, making Mississippi the 37th state to adopt medical cannabis laws. On January 26, 2022, the state legislature passed SB 2095, their watered down vision for medical cannabis in Mississippi. . ASA strongly opposes both of these provisions.

Access 264
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CBD Enhances Glucose Metabolism via Nuclear Receptors

Project CBD

He had never taken anti-psychotic drugs nor received psychological treatment. Due to its excellent tolerability and promising efficacy … and its innovative new mechanisms of action, we decided to offer a respective treatment with cannabidiol to [the] patient,” they write. Cannabidiol as a potential treatment for psychosis.”

CBD 294
article thumbnail

Significant Decrease in Mental Health Treatment Seen in States With Legal Cannabis

Veriheal

States legalizing recreational cannabis are seeing an unexpected and significant decrease in mental health treatment admissions. The data revealed that shortly after the adoption of recreational marijuana laws, states began to see fewer admissions to treatment centers for mental illness. It intensifies as time progresses.

article thumbnail

Beta-Caryophyllene: Terpene Powerhouse

Project CBD

More recently, a July 2022 paper in BioFactors 8 by Iranian scientists reviewed the antioxidant and immunomodulatory effects of beta-caryophyllene, which was shown to reduce relevant proinflammatory cytokines while increasing anti-inflammatory cytokines. 48,4 (2022): 857-882. Pharmacology vol. 94,1-2 (2014): 1-12. doi:10.1002/biof.1869

Terpenes 232
article thumbnail

The Scott of Pot At It Again. Cann Group aiming for over-the-counter CBD approval in late 2022

Cannabis Law Report

Phase II clinical trial of the Satipharm CBD capsules showed significantly reduced monthly seizure frequency in the treatment of children suffering from refractory, or treatment-resistant epilepsy when the Satipharm capsules were added to current medications. following 12 weeks of treatment.

article thumbnail

Veriheal’s 2022 Innovation in Cannabis Scholarship Winners

Veriheal

We are honored to present the five recipients of Veriheal’s 2022 Innovation in Cannabis Scholarship. Innovation: The cannabis plant’s naturality is one of its biggest draws as a medical treatment, but cultivating it isn’t always great for the environment due to factors like heavy fertilizer use and high water consumption.

Education 105